ALESHIA WILLIAMS: Open Payments
NPI 1407463938 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 11 payments from 7 companies in 2025. Trend: 2023 $130 · 2024 $213 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $273 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $50 |
| Lilly USA, LLC | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| ViiV Healthcare Company | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: Epclusa, JOURNAVX, JARDIANCE, Kerendia, RUKOBIA, GEMTESA, CAPVAXIVE.
Industry payments across AR — which companies pay providers there.
